General Information of Drug (ID: DMOTI0P)

Drug Name
H-Tyr-c[D-Orn-Aic-Glu]-NH2
Synonyms CHEMBL106849; H-Tyr-c[D-Orn-Aic-Glu]-NH2
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 2 Molecular Weight (mw) 564.6
Logarithm of the Partition Coefficient (xlogp) -0.1
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 7
Hydrogen Bond Acceptor Count (hbondacc) 7
Chemical Identifiers
Formula
C29H36N6O6
IUPAC Name
(5'R,13'S)-13'-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3',8',14'-trioxospiro[1,3-dihydroindene-2,2'-1,4,9-triazacyclotetradecane]-5'-carboxamide
Canonical SMILES
C1C[C@@H](C(=O)NC2(CC3=CC=CC=C3C2)C(=O)N[C@H](CCC(=O)NC1)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N
InChI
InChI=1S/C29H36N6O6/c30-21(14-17-7-9-20(36)10-8-17)26(39)33-23-6-3-13-32-24(37)12-11-22(25(31)38)34-28(41)29(35-27(23)40)15-18-4-1-2-5-19(18)16-29/h1-2,4-5,7-10,21-23,36H,3,6,11-16,30H2,(H2,31,38)(H,32,37)(H,33,39)(H,34,41)(H,35,40)/t21-,22+,23-/m0/s1
InChIKey
YFKXNEKIMXIPLT-ZRBLBEILSA-N
Cross-matching ID
PubChem CID
44336496
TTD ID
D03CKF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Opioid receptor delta (OPRD1) TT27RFC OPRD_HUMAN Inhibitor [1]
Opioid receptor mu (MOP) TTKWM86 OPRM_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Opioid receptor mu (MOP) DTT OPRM1 5.94E-01 -0.02 -0.17
Opioid receptor delta (OPRD1) DTT OPRD1 5.52E-01 0.03 0.23
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. J Med Chem. 1991 Oct;34(10):3125-32.